tirzepatide for alcohol use disorder Can a weight loss drug reduce cravings Tirzepatide reduces alcohol drinking and

Semaglutide significantly reduces caloric intake by increasing feelings of fullness and decreasing hunger, leading to substantial weight loss in clinical trials

Zenobi PD, Glatz Y, Keller A, Graf S, Jaeggi-Groisman SE, Riesen WF, Schoenle EJ, Froesch ER

They can hinder weight loss efforts and cause blood sugar spikes

This is known as the plateau, and it can happen when you lose too much muscle and fat simultaneously

Here are the main concerns: Interference with Fetal Development Since tirzepatide affects blood sugar levels and other metabolic processes, there is a possibility that it could interfere with the normal development of the fetus

Notably, orforglipron exhibited the highest risk, followed by exenatide, tirzepatide, semaglutide, and liraglutide